NVO - Lilly reportedly worried about impact of Catalent/Novo deal
2024-02-06 13:23:49 ET
More on Catalent, Eli Lilly, etc.
- Eli Lilly and Company 2023 Q4 - Results - Earnings Call Presentation
- Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value
- Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript
- Biggest stock movers today: DocuSign, BP, Palantir Technologies, and more
- 6 stocks to watch on Tuesday: Spotify, Eli Lilly, Chipotle, DocuSign and more